Objective: To evaluate intraocular pressure (IOP) control, change in visual
acuity, and complications in eyes that have undergone a second glaucoma tu
be shunt procedure.
Design: Retrospective, noncomparative case series.
Participants: Twenty-two eyes of 22 patients that have undergone sequential
tube implants for management of glaucoma,
Methods: Parameters analyzed included IOP, visual acuity, and number of hyp
otensive agent before each shunt procedure and at last follow-up visit. The
overall IOP lowering effect attributable to each tube shunt was calculated
. Any ocular complications after the second tube shunt were recorded. Succe
ss was defined as an IOP between 6 and 21 mmHg and a 20% reduction in IOP f
rom the second tube shunt procedure. Qualified successes met one of these t
wo requirements at the last follow-up visit. Total failures did not meet an
y of the above criteria, required additional surgical intervention to lower
IOP, or both.
Main Outcome Measures: Intraocular pressure control, visual acuity preserva
tion, and complications.
Results: At the last follow-up visit, the average percent reduction in IOP
from both tube shunt procedures was 42 +/- 21%, The average percent IOP red
uction from the second tube shunt was 33 +/- 17%. Eleven (50%) patients met
the criteria for success, 8 (36.4%) patients were qualified successes, and
3 (13.6%) were failures. The median number of hypotensive agents decreased
from two to one. Ten patients experienced new or worse pseudophakic bullou
s keratopathy after the second tube shunt, six of whom underwent penetratin
g keratoplasty. Thirteen (59%) patients maintained visual acuity within one
line of their second tube shunt pre-operative Snellen visual acuity. Seven
(32%) patients lost more than 2 lines, and one patient lost light percepti
on,
Conclusions: Although corneal morbidity is a common complication, a second
tube shunt does not cause higher-than-expected rates of other complications
associated with tube shunt surgery. Eyes that undergo a second tube shunt
procedure can achieve pressure control, require fewer hypotensive agents, a
nd may maintain stable visual acuity. (C) 2000 by the American Academy of O
phthalmology.